APO-GO is a medication primarily used in the management and treatment of Parkinson's disease and parkinsonism. It contains the active ingredient apomorphine, which belongs to a class of drugs known as dopamine agonists. APO-GO works by stimulating dopamine receptors in the brain, helping to alleviate symptoms such as tremors, stiffness, and movement difficulties associated with Parkinson's disease. It is often used in patients for whom other treatments have not been effective. APO-GO can be administered in various forms, including injections and infusion pumps, providing flexibility in managing the condition's symptoms. As with any medication, it is important to use APO-GO under the guidance of a healthcare professional to ensure its safe and effective use.
Your cart contains products from a separate order category. Adding this product will remove those items from your cart.
Important Supply & Pricing Update about GLP-1 Medications
Due to manufacturer-driven price increases from Eli Lilly and other suppliers, prices for GLP-1 medications including Mounjaro have risen significantly. Global supply constraints may also result in slightly longer lead times.
We remain committed to securing the best possible pricing and supply for our customers and will continue to provide updates as the situationĀ evolves.